Chargement en cours...
Initial Physician Experience with [(18)F]Flutemetamol Amyloid PET Imaging Following Availability for Routine Clinical Use in Japan
BACKGROUND: Brain amyloid is a neuropathological hallmark of Alzheimer’s disease (AD). By visualizing brain amyloid, positron emission tomography (PET) may influence the diagnostic assessment and management of patients with cognitive impairment. OBJECTIVE: As part of a Japanese post-approval study t...
Enregistré dans:
| Publié dans: | J Alzheimers Dis Rep |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
IOS Press
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7369136/ https://ncbi.nlm.nih.gov/pubmed/32715277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/ADR-190150 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|